1. Chemotherapy appears to be independently associated with reduced pain severity in advanced pancreatic cancer, reinforcing the importance of routine,...
1. The FDA approved orforglipron (Foundayo) on April 1, 2026, making it the first non-peptide oral GLP-1 receptor agonist cleared...
1. Although neurological symptoms (motor deficits, sensory impairment) were more frequent in patients with sitting-related sacral pain on univariate comparison,...
1. Adults who received cryoanalgesia during minimally invasive thoracic surgery experienced higher neuropathic pain scores at three, six, and twelve...
1. Among children with inflammatory bowel disease, there were no significant differences in serious or outpatient infection risk between initiating...
1. A University of Calgary study published in Science Advances this month found that chronic wasting disease can spread silently...
1. Immediate septoplasty is more costly but more clinically effective than medical management for deviated septum. 2. Over a 24-month...
1. In this cross-sectional study, one-third of federally qualified health centers (FQHCs) in the United States did not provide onsite...
1. In this cohort study, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a higher risk of anterior ischemic...
1. In this target trial emulation, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with a small increase in the...
